Cover art for ST Xiangxue Restructuring Accepted by Court

ST Xiangxue Restructuring Accepted by Court

Guangzhou Intermediate Court accepts *ST Xiangxue's restructuring, risking delisting with negative net assets of CNY 773 million.

By ·

Nov 19, 2026

7 cards · 1m 20s · tap to begin

From · · · 1m 20s

ST Xiangxue Restructuring Accepted by Court

Guangzhou Intermediate Court accepts *ST Xiangxue's restructuring, risking delisting with negative net assets of CNY 773 million.

In brief

Guangzhou Intermediate Court accepts *ST Xiangxue's restructuring, risking delisting with negative net assets of CNY 773 million. Guangdong pharmaceutical company *ST Xiangxue's restructuring was accepted by Guangzhou Intermediate Court, putting it at risk of delisting due to negative net assets of CNY 773 million…

Court Accepts Restructuring

*ST Xiangxue's Restructuring Accepted by Guangzhou Intermediate Court; Negative Net Assets of CNY 773 Million Put It at Risk of Delisting

Guangzhou Intermediate People's Court accepted restructuring applications filed by Guangzhou Rural Commercial Bank's Huangpu Branch and Guangzhou High-Tech Zone Financial Leasing.

Creditors Must File Claims

Creditors must file claims with administrators by December 18, 2026, with first creditors' meeting scheduled for December 19.

Five Years of Losses

Company reported cumulative losses exceeding cny 3.8 billion from 2021 to 2025, including cny 1.392 billion loss in 2025.

Negative Net Assets

*ST Xiangxue's Restructuring Accepted by Guangzhou Intermediate Court; Negative Net Assets of CNY 773 Million Put It at Risk of Delisting

Company reported negative net assets of cny 773 million at end of third quarter 2026.

Additional Delisting Risk

Shares face additional delisting risk warning starting November 20, 2026 if restructuring fails or net assets remain negative.

Restructuring Risks

Court acceptance does not guarantee success; failure could lead to bankruptcy and liquidation.

Delisting Conditions

Company could face delisting if net assets remain negative at end of fiscal 2026.

The key point

Guangdong pharmaceutical company *ST Xiangxue's restructuring was accepted by Guangzhou Intermediate Court, putting it at risk of delisting due to negative net assets of CNY 773 million.

Read the original on BigGo Finance

Read the TL;DR — this story on one card.

How we make summaries

React

Sign in to react and comment.

Comments (0)

Life is short. Keep it sweet. Respect others' opinions and be kind!

    Recommended next

    More decks on guangzhou intermediate people's court and related topics.